Christopher P. Molineaux

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher P. Molineaux:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Director Common Stock 58K $88.7K $1.53 Jun 6, 2025 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $4.94K $1.03 Jun 6, 2025 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 42.4K Jun 5, 2025 Direct

Insider Reports Filed by Christopher P. Molineaux

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Jun 5, 2025 4 $0 4 Jun 9, 2025 Director
ACRS Aclaris Therapeutics, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 20, 2023 2 $23.3K 4 Jun 22, 2023 Director
ACRS Aclaris Therapeutics, Inc. Jun 15, 2023 4 $338 4 Jun 20, 2023 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2023 4 $0 4 Jun 5, 2023 Director
ACRS Aclaris Therapeutics, Inc. Jun 2, 2022 4 $0 4 Jun 6, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jun 3, 2021 2 $0 4 Jun 4, 2021 Director